August 1, 2018 (Vol. 38, No. 14)

Expedeon

2view is a double-labeled, secondary antibody that enables extended detection within the widely used Western blot application. The product consists of a ternary complex developed using the company’s world-leading InnovaCoat and Lightning-Link technology. 2view secondary antibodies are labeled simultaneously with a visible chemi-luminescent enzymatic detection system. The gold nanoparticles enable fast visible detection at nanogram level whereas the enzymatic detection mechanism enhances sensitivity down to picogram levels of protein.

Previous articleDNA Crosslink Repair Central to CRISPR Insert Success
Next articleCancer Cells Feel Acid’s Sting